---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Abridge

🌎 abridge.com

Abridge is a healthcare technology company founded in 2018 that specializes in transforming patient-clinician conversations into structured clinical notes using generative AI. Their platform enhances clinical documentation efficiency, allowing clinicians to focus on patient care while ensuring accurate and auditable AI-generated summaries. Abridge integrates deeply with electronic medical records (EMR) systems, setting industry standards for the responsible use of AI in healthcare.

---

Abridge - Latest News and Updates

• Abridge appointed Sagar Sanghvi as Chief Financial Officer on January 31, 2025, and launched Abridge Inside for Emergency Medicine as part of Epic's workshop program.
• Abridge appointed Mario Queiroz as Chief Product Officer and Sagar Sanghvi as Chief Financial Officer, while Daniel Gloede, SVP of Finance and Operations, is no longer listed.
• Sagar Sanghvi has joined Abridge as CFO in the United States, previously holding a position at another company.
• Abridge, Ambience Healthcare, and Insight Health have launched new AI tools for electronic health records to enhance provider operations and patient care.
• Mount Sinai Medical Center is using Abridge to record and transcribe physicians' notes in real time, reducing charting time and helping to decrease physician burnout.

• Abridge is currently seeking a Data Ops Leader, Annotations & Datasets in the United States.
• Amanda Pritts has joined Abridge as Partner Success Director in the United States, previously holding a position at another company.
• Abridge hosted 'The Conversation' event featuring notable figures like Arianna Huffington and Douglas Rushkoff to inspire innovation in healthcare and AI.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.